Testing myWHI: Online Self-help Programs for Headaches

计划入组 424 人 · 首次发布于 2018 年 4 月 20 日

PRISM Trial

计划入组 4,800 人

PRISM Intervention Study

计划入组 140 人 · 首次发布于 2019 年 3 月 20 日

prismocitrate 18

PRIM-DJ2727

Potassium chloride(Bi-peglyte, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Colyte, Dextrose and Electrolyte No. 75, Diphen, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Glycerolyte 57, Golytely, H.E.L.P.bicel, Hemosate Ultra, Ionosol-MB, Isolyte P, Isolyte S, Isolyte S pH 7.4, Isoplate, K 45, K-tab, Klor-con, Lactated Ringers, Moviprep, Naturalyte, Normosol-R, Nulytely, Nxstage Pureflow, Olimel, Peglyte, Periolimel, Phoxillum, Physiolyte, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Pokonza, Prismasol, Procalamine 3, Ringers, Selectbag One, Suflave, Tis-U-sol)

<dd class="col-xl-8 col-md-9 col-sm-8">ClK</dd>

PRISM PHARMACEUTICALS

Pakistan

PF PRISM C.V.

Netherlands

PRISM Pharma Co., Ltd.

Japan

PRISM BioLab Achieves First Milestone in Oncology Drug Discovery Partnership with Ono Pharmaceutical

Cardiol Therapeutics Added to PRISM Emerging Biotech Index

PRISM BioLab and Talus Bioscience Partner to Target Previously Undruggable Protein Interactions Using AI-Guided Drug Discovery